

THE Australian Government and Advanced Pharmacy Australia (AdPha) have broadly welcomed and endorsed the World Health Organization’s (WHO) new Pandemic Agreement, which lays out a coordinated global response against future outbreaks.
THE Therapeutic Goods Administration (TGA) has registered Kisunla (donanemab, Eli Lilly) for the treatment of adults with early symptomatic Alzheimer’s disease who have a specific genetic profile and the confirmed presence of amyloid plaque in the brain.
IN partnership with CARMEX
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.
Notifications